Skip to main content

SCCS for Detection of Differences in Brand and Generic Adverse Drug Events.

Publication ,  Conference
Badger, JC; LaRose, ER; Kleiman, R; Berg, RL; Linneman, JG; Hansen, R; Page, D; Peissig, PL
Published in: CRI
2017

Duke Scholars

Published In

CRI

Publication Date

2017

Publisher

AMIA
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Badger, J. C., LaRose, E. R., Kleiman, R., Berg, R. L., Linneman, J. G., Hansen, R., … Peissig, P. L. (2017). SCCS for Detection of Differences in Brand and Generic Adverse Drug Events. In CRI. AMIA.
Badger, Jonathan C., Eric R. LaRose, Ross Kleiman, Richard L. Berg, James G. Linneman, Richard Hansen, David Page, and Peggy L. Peissig. “SCCS for Detection of Differences in Brand and Generic Adverse Drug Events.” In CRI. AMIA, 2017.
Badger JC, LaRose ER, Kleiman R, Berg RL, Linneman JG, Hansen R, et al. SCCS for Detection of Differences in Brand and Generic Adverse Drug Events. In: CRI. AMIA; 2017.
Badger, Jonathan C., et al. “SCCS for Detection of Differences in Brand and Generic Adverse Drug Events.CRI, AMIA, 2017.
Badger JC, LaRose ER, Kleiman R, Berg RL, Linneman JG, Hansen R, Page D, Peissig PL. SCCS for Detection of Differences in Brand and Generic Adverse Drug Events. CRI. AMIA; 2017.

Published In

CRI

Publication Date

2017

Publisher

AMIA